The Hydroponics Company gets import approval, provides …

The Hydroponics Company ASX THC import approval medicinal cannabis tourette's syndrome clinical trial

The Hydroponics Company (ASX: THC) has been given the green light to import medicinal cannabis products from its European partner Endoca after locking in a distribution deal last November.

The company also today announced it will be supporting an upcoming clinical trial for the treatment of Tourette’s Syndrome, via its recent collaboration with BOL Pharma.

In November last year, The Hydroponics Company’s wholly-owned subsidiary Canndeo Ltd secured an agreement with Endoca to distribute medicinal cannabis products throughout Australia.

The company today reported the Drug Control Section

... read more at: